Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179
In the original publication [...]
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-08-01
|
| Series: | Future Pharmacology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-9879/3/3/36 |
| _version_ | 1797579926048604160 |
|---|---|
| author | Tâmara Dauare de Almeida Fernanda Cristina Gontijo Evangelista Adriano de Paula Sabino |
| author_facet | Tâmara Dauare de Almeida Fernanda Cristina Gontijo Evangelista Adriano de Paula Sabino |
| author_sort | Tâmara Dauare de Almeida |
| collection | DOAJ |
| description | In the original publication [...] |
| first_indexed | 2024-03-10T22:43:58Z |
| format | Article |
| id | doaj.art-0b2eb7c9b75d4d8888efb17c8dbf7c4e |
| institution | Directory Open Access Journal |
| issn | 2673-9879 |
| language | English |
| last_indexed | 2024-03-10T22:43:58Z |
| publishDate | 2023-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Future Pharmacology |
| spelling | doaj.art-0b2eb7c9b75d4d8888efb17c8dbf7c4e2023-11-19T10:49:33ZengMDPI AGFuture Pharmacology2673-98792023-08-013358558510.3390/futurepharmacol3030036Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179Tâmara Dauare de Almeida0Fernanda Cristina Gontijo Evangelista1Adriano de Paula Sabino2Clinical and Toxicological Analysis Department, College of Pharmacy, Federal University of Minas Gerais, Avenue Presidente Antônio Carlos, 6627 Pampulha, Belo Horizonte 31270-901, MG, BrazilClinical and Toxicological Analysis Department, College of Pharmacy, Federal University of Minas Gerais, Avenue Presidente Antônio Carlos, 6627 Pampulha, Belo Horizonte 31270-901, MG, BrazilClinical and Toxicological Analysis Department, College of Pharmacy, Federal University of Minas Gerais, Avenue Presidente Antônio Carlos, 6627 Pampulha, Belo Horizonte 31270-901, MG, BrazilIn the original publication [...]https://www.mdpi.com/2673-9879/3/3/36n/a |
| spellingShingle | Tâmara Dauare de Almeida Fernanda Cristina Gontijo Evangelista Adriano de Paula Sabino Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 Future Pharmacology n/a |
| title | Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 |
| title_full | Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 |
| title_fullStr | Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 |
| title_full_unstemmed | Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 |
| title_short | Correction: de Almeida et al. Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity. <i>Future Pharmacol.</i> 2023, <i>3</i>, 162–179 |
| title_sort | correction de almeida et al acute promyelocytic leukemia apl a review of the classic and emerging target therapies towards molecular heterogeneity i future pharmacol i 2023 i 3 i 162 179 |
| topic | n/a |
| url | https://www.mdpi.com/2673-9879/3/3/36 |
| work_keys_str_mv | AT tamaradauaredealmeida correctiondealmeidaetalacutepromyelocyticleukemiaaplareviewoftheclassicandemergingtargettherapiestowardsmolecularheterogeneityifuturepharmacoli2023i3i162179 AT fernandacristinagontijoevangelista correctiondealmeidaetalacutepromyelocyticleukemiaaplareviewoftheclassicandemergingtargettherapiestowardsmolecularheterogeneityifuturepharmacoli2023i3i162179 AT adrianodepaulasabino correctiondealmeidaetalacutepromyelocyticleukemiaaplareviewoftheclassicandemergingtargettherapiestowardsmolecularheterogeneityifuturepharmacoli2023i3i162179 |